Alexa Fluor 546-ArIB[V11L;V16A] is a potent ligand for selectively labeling 7 nicotinic acetylcholine receptors

Journal of Neurochemistry

Volumn 114, Issue 4, 2010, Pages 994-1006

  Hone, Arik J ^a   Whiteaker, Paul ^b   Mohn, Jesse L ^c   Jacob, Michele H ^c   Michael McIntosh, J ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b BARROW NEUROLOGICAL INSTITUTE   (United States)

^c TUFTS UNIVERSITY   (United States)

Author keywords

conotoxin; 7 nicotinic Ach receptor; fluorescence; hippocampal neurons

Indexed keywords

ALEXA FLUOR 546 N HYDROXYSUCCINIMIDYL ESTER DYE; ALPHA BUNGAROTOXIN; BUNGAROTOXIN RECEPTOR; CY3 N HYDROXYSUCCINIMIDYL ESTER DYE; FLUORESCENT DYE; NICOTINIC RECEPTOR; UNCLASSIFIED DRUG; ALEXA FLUOR 546; ALPHA-CONOTOXIN IB, LEU(11), ASP(16)-; CHRNA7 PROTEIN, HUMAN; CHRNA7 PROTEIN, MOUSE; CHRNA7 PROTEIN, RAT; CONOTOXIN; LIGAND; PROTEIN BINDING; QUINOLINE DERIVATIVE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BLEACHING; BRAIN MEMBRANE; BRAIN NERVE CELL; CELL LABELING; CONTROLLED STUDY; FLUORESCENCE; HUMAN; HUMAN CELL; IC 50; KIDNEY CELL; MOUSE; NONHUMAN; OOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RECEPTOR BINDING; STABLE TRANSFECTION; WILD TYPE; XENOPUS; ANIMAL; BINDING COMPETITION; C57BL MOUSE; CELL CULTURE; CELL LINE; CHEMISTRY; CYTOLOGY; DEFICIENCY; FEMALE; GENETICS; HIPPOCAMPUS; KNOCKOUT MOUSE; METABOLISM; NERVE CELL; PHYSIOLOGY; PROCEDURES; STAINING; XENOPUS LAEVIS;

ALEXA; MUS; RATTUS; VERTEBRATA;

ALPHA7 NICOTINIC ACETYLCHOLINE RECEPTOR; ANIMALS; BINDING, COMPETITIVE; CELL LINE; CELLS, CULTURED; CONOTOXINS; FEMALE; FLUORESCENT DYES; HIPPOCAMPUS; HUMANS; LIGANDS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NEURONS; OOCYTES; PROTEIN BINDING; QUINOLINIUM COMPOUNDS; RATS; RECEPTORS, NICOTINIC; STAINING AND LABELING; XENOPUS LAEVIS;

EID: 77954746026     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2010.06819.x     Document Type: Article

References (65)

1. Albuquerque E. X., Pereira E. F., Braga M. F., Matsubayashi H. Alkondon M. (1998) Neuronal nicotinic receptors modulate synaptic function in the hippocampus and are sensitive to blockade by the convulsant strychnine and by the anti-Parkinson drug amantadine. Toxicol. Lett. 102-103, 211 218.
2. Albuquerque E. X., Pereira E. F., Alkondon M. Rogers S. W. (2009) Mammalian nicotinic acetylcholine receptors: from structure to function. Physiol. Rev. 89, 73 120.
3. Alkondon M. Albuquerque E. X. (2002) A non-alpha7 nicotinic acetylcholine receptor modulates excitatory input to hippocampal CA1 interneurons. J. Neurophysiol. 87, 1651 1654.
4. Alkondon M., Pereira E. F., Barbosa C. T. Albuquerque E. X. (1997) Neuronal nicotinic acetylcholine receptor activation modulates gamma-aminobutyric acid release from CA1 neurons of rat hippocampal slices. J. Pharmacol. Exp. Ther. 283, 1396 1411.
5. Alkondon M., Pereira E. F., Eisenberg H. M. Albuquerque E. X. (1999) Choline and selective antagonists identify two subtypes of nicotinic acetylcholine receptors that modulate GABA release from CA1 interneurons in rat hippocampal slices. J. Neurosci. 19, 2693 2705.
6. Bencherif M. Lippiello P. M. (2010) Alpha7 neuronal nicotinic receptors: the missing link to understanding Alzheimer's etiopathology? Med. Hypotheses 74, 281 285.
7. Berlier J. E., Rothe A., Buller G. et al. (2003) Quantitative comparison of long-wavelength Alexa Fluor dyes to Cy dyes: fluorescence of the dyes and their bioconjugates. J. Histochem. Cytochem. 51, 1699 1712.
8. Biallas S., Wilker S., Lips K. S., Kummer W., Grando S. A., Padberg W. Grau V. (2007) Immunohistochemical detection of nicotinic acetylcholine receptor subunits alpha9 and alpha10 in rat lung isografts and allografts. Life Sci. 80, 2286 2289.
9. Buccafusco J. J. Terry Jr. A. V. (2009) A reversible model of the cognitive impairment associated with schizophrenia in monkeys: potential therapeutic effects of two nicotinic acetylcholine receptor agonists. Biochem. Pharmacol. 78, 852 862.
10. Buckley K. Kelly R. B. (1985) Identification of a transmembrane glycoprotein specific for secretory vesicles of neural and endocrine cells. J. Cell Biol. 100, 1284 1294.
11. Buhler A. V. Dunwiddie T. V. (2002) alpha7 nicotinic acetylcholine receptors on GABAergic interneurons evoke dendritic and somatic inhibition of hippocampal neurons. J. Neurophysiol. 87, 548 557.
12. Cartier G. E., Yoshikami D., Gray W. R., Luo S., Olivera B. M. McIntosh J. M. (1996) A new alpha-conotoxin which targets alpha3beta2 nicotinic acetylcholine receptors. J. Biol. Chem. 271, 7522 7528.
13. Cheng Y. Prusoff W. H. (1973) Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction. Biochem. Pharmacol. 22, 3099 3108.
14. Davila-Garcia M. I., Musachio J. L., Perry D. C., Xiao Y., Horti A., London E. D., Dannals R. F. Kellar K. J. (1997) [125I]IPH, an epibatidine analog, binds with high affinity to neuronal nicotinic cholinergic receptors. J. Pharmacol. Exp. Ther. 282, 445 451.
15. Dziewczapolski G., Glogowski C. M., Masliah E. Heinemann S. F. (2009) Deletion of the alpha 7 nicotinic acetylcholine receptor gene improves cognitive deficits and synaptic pathology in a mouse model of Alzheimer's disease. J. Neurosci. 29, 8805 8815.
16. Elgoyhen A. B., Johnson D. S., Boulter J., Vetter D. E. Heinemann S. (1994) Alpha 9: an acetylcholine receptor with novel pharmacological properties expressed in rat cochlear hair cells. Cell 79, 705 715.
17. Elgoyhen A. B., Vetter D. E., Katz E., Rothlin C. V., Heinemann S. F. Boulter J. (2001) alpha10: a determinant of nicotinic cholinergic receptor function in mammalian vestibular and cochlear mechanosensory hair cells. Proc. Natl Acad. Sci. USA 98, 3501 3506.
18. Fayuk D. Yakel J. L. (2007) Dendritic Ca2+ signalling due to activation of alpha 7-containing nicotinic acetylcholine receptors in rat hippocampal neurons. J. Physiol. 582, 597 611.
19. Franceschini D., Paylor R., Broide R., Salas R., Bassetto L., Gotti C. De Biasi M. (2002) Absence of alpha7-containing neuronal nicotinic acetylcholine receptors does not prevent nicotine-induced seizures. Brain Res. Mol. Brain Res. 98, 29 40.
20. Frazier C. J., Rollins Y. D., Breese C. R., Leonard S., Freedman R. Dunwiddie T. V. (1998) Acetylcholine activates an alpha-bungarotoxin-sensitive nicotinic current in rat hippocampal interneurons, but not pyramidal cells. J. Neurosci. 18, 1187 1195.
21. Frazier C. J., Strowbridge B. W. Papke R. L. (2003) Nicotinic receptors on local circuit neurons in dentate gyrus: a potential role in regulation of granule cell excitability. J. Neurophysiol. 89, 3018 3028.
22. Fucile S., Renzi M., Lax P. Eusebi F. (2003) Fractional Ca(2+) current through human neuronal alpha7 nicotinic acetylcholine receptors. Cell Calcium 34, 205 209.
23. Gahring L. C., Persiyanov K., Dunn D., Weiss R., Meyer E. L. Rogers S. W. (2004) Mouse strain-specific nicotinic acetylcholine receptor expression by inhibitory interneurons and astrocytes in the dorsal hippocampus. J. Comp. Neurol. 468, 334 346.
24. Grau V., Wilker S., Hartmann P., Lips K. S., Grando S. A., Padberg W., Fehrenbach H. Kummer W. (2007) Administration of keratinocyte growth factor (KGF) modulates the pulmonary expression of nicotinic acetylcholine receptor subunits alpha7, alpha9 and alpha10. Life Sci. 80, 2290 2293.
25. Haberberger R. V., Bernardini N., Kress M., Hartmann P., Lips K. S. Kummer W. (2004) Nicotinic acetylcholine receptor subtypes in nociceptive dorsal root ganglion neurons of the adult rat. Auton. Neurosci. 113, 32 42. (Pubitemid 39024511)
26. Hauser T. A., Kucinski A., Jordan K. G. et al. (2009) TC-5619: an alpha7 neuronal nicotinic receptor-selective agonist that demonstrates efficacy in animal models of the positive and negative symptoms and cognitive dysfunction of schizophrenia. Biochem. Pharmacol. 78, 803 812.
27. Herber D. L., Severance E. G., Cuevas J., Morgan D. Gordon M. N. (2004) Biochemical and histochemical evidence of nonspecific binding of alpha7nAChR antibodies to mouse brain tissue. J. Histochem. Cytochem. 52, 1367 1376.
28. Hone A. J., Whiteaker P., Christensen S., Xiao Y., Meyer E. L. McIntosh J. M. (2009) A novel fluorescent alpha-conotoxin for the study of alpha7 nicotinic acetylcholine receptors. J. Neurochem. 111, 80 89.
29. Kannenberg K., Sieghart W. Reuter H. (1999) Clusters of GABAA receptors on cultured hippocampal cells correlate only partially with functional synapses. Eur. J. Neurosci. 11, 1256 1264.
30. Kawai H., Zago W. Berg D. K. (2002) Nicotinic alpha 7 receptor clusters on hippocampal GABAergic neurons: regulation by synaptic activity and neurotrophins. J. Neurosci. 22, 7903 7912.
31. Khiroug L., Giniatullin R., Klein R. C., Fayuk D. Yakel J. L. (2003) Functional mapping and Ca2+ regulation of nicotinic acetylcholine receptor channels in rat hippocampal CA1 neurons. J. Neurosci. 23, 9024 9031.
32. Mao D., Perry D. C., Yasuda R. P., Wolfe B. B. Kellar K. J. (2008) The alpha4beta2alpha5 nicotinic cholinergic receptor in rat brain is resistant to up-regulation by nicotine in vivo. J. Neurochem. 104, 446 456.
33. Marchionni I., Omrani A. Cherubini E. (2007) In the developing rat hippocampus a tonic GABAA-mediated conductance selectively enhances the glutamatergic drive of principal cells. J. Physiol. 581, 515 528.
34. Marks M. J., Wageman C. R., Grady S. R., Gopalakrishnan M. Briggs C. A. (2009) Selectivity of ABT-089 for alpha4beta2* and alpha6beta2* nicotinic acetylcholine receptors in brain. Biochem. Pharmacol. 78, 795 802.
35. Massey K. A., Zago W. M. Berg D. K. (2006) BDNF up-regulates alpha7 nicotinic acetylcholine receptor levels on subpopulations of hippocampal interneurons. Mol. Cell. Neurosci. 33, 381 388.
36. McCann C. M., Bracamontes J., Steinbach J. H. Sanes J. R. (2006) The cholinergic antagonist alpha-bungarotoxin also binds and blocks a subset of GABA receptors. Proc. Natl Acad. Sci. USA 103, 5149 5154.
37. McQuiston A. R. Madison D. V. (1999) Nicotinic receptor activation excites distinct subtypes of interneurons in the rat hippocampus. J. Neurosci. 19, 2887 2896.
38. Mexal S., Berger R., Logel J., Ross R. G., Freedman R. Leonard S. (2010) Differential regulation of alpha7 nicotinic receptor gene (CHRNA7) expression in schizophrenic smokers. J. Mol. Neurosci. 40, 185 195.
39. Moser N., Mechawar N., Jones I. et al. (2007) Evaluating the suitability of nicotinic acetylcholine receptor antibodies for standard immunodetection procedures. J. Neurochem. 102, 479 492.
40. Orr-Urtreger A., Goldner F. M., Saeki M., Lorenzo I., Goldberg L., De Biasi M., Dani J. A., Patrick J. W. Beaudet A. L. (1997) Mice deficient in the alpha7 neuronal nicotinic acetylcholine receptor lack alpha-bungarotoxin binding sites and hippocampal fast nicotinic currents. J. Neurosci. 17, 9165 9171.
41. Palma E., Bertrand S., Binzoni T. Bertrand D. (1996) Neuronal nicotinic alpha 7 receptor expressed in Xenopus oocytes presents five putative binding sites for methyllycaconitine. J. Physiol. 491 (Pt 1 151 161.
42. Panchuk-Voloshina N., Haugland R. P., Bishop-Stewart J., Bhalgat M. K., Millard P. J., Mao F. Leung W. Y. (1999) Alexa dyes, a series of new fluorescent dyes that yield exceptionally bright, photostable conjugates. J. Histochem. Cytochem. 47, 1179 1188.
43. Peng H., Ferris R. L., Matthews T., Hiel H., Lopez-Albaitero A. Lustig L. R. (2004) Characterization of the human nicotinic acetylcholine receptor subunit alpha (alpha) 9 (CHRNA9) and alpha (alpha) 10 (CHRNA10) in lymphocytes. Life Sci. 76, 263 280.
44. Perry D. C. Kellar K. J. (1995) [3H]epibatidine labels nicotinic receptors in rat brain: an autoradiographic study. J. Pharmacol. Exp. Ther. 275, 1030 1034.
45. Placzek A. N., Zhang T. A. Dani J. A. (2009) Nicotinic mechanisms influencing synaptic plasticity in the hippocampus. Acta Pharmacol. Sin. 30, 752 760.
46. Rosenberg M. M., Yang F., Giovanni M., Mohn J. L., Temburni M. K. Jacob M. H. (2008) Adenomatous polyposis coli plays a key role, in vivo, in coordinating assembly of the neuronal nicotinic postsynaptic complex. Mol. Cell. Neurosci. 38, 138 152.
47. Salminen O., Whiteaker P., Grady S. R., Collins A. C., McIntosh J. M. Marks M. J. (2005) The subunit composition and pharmacology of alpha-Conotoxin MII-binding nicotinic acetylcholine receptors studied by a novel membrane-binding assay. Neuropharmacology 48, 696 705.
48. Sgard F., Charpantier E., Bertrand S., Walker N., Caput D., Graham D., Bertrand D. Besnard F. (2002) A novel human nicotinic receptor subunit, alpha10, that confers functionality to the alpha9-subunit. Mol. Pharmacol. 61, 150 159.
49. Sharma G., Grybko M. Vijayaraghavan S. (2008) Action potential- independent and nicotinic receptor-mediated concerted release of multiple quanta at hippocampal CA3-mossy fiber synapses. J. Neurosci. 28, 2563 2575.
50. Sinkus M. L., Lee M. J., Gault J., Logel J., Short M., Freedman R., Christian S. L., Lyon J. Leonard S. (2009) A 2-base pair deletion polymorphism in the partial duplication of the alpha7 nicotinic acetylcholine gene (CHRFAM7A) on chromosome 15q14 is associated with schizophrenia. Brain Res. 1291, 1 11.
51. Sudweeks S. N. Yakel J. L. (2000) Functional and molecular characterization of neuronal nicotinic ACh receptors in rat CA1 hippocampal neurons. J. Physiol. 527 (Pt 3 515 528.
52. Szabo S. I., Zelles T. Lendvai B. (2008) Intracellular Ca2+ dynamics of hippocampal interneurons following nicotinic acetylcholine receptor activation. Neurochem. Int. 52, 135 141.
53. Tretter V., Jacob T. C., Mukherjee J., Fritschy J. M., Pangalos M. N. Moss S. J. (2008) The clustering of GABA(A) receptor subtypes at inhibitory synapses is facilitated via the direct binding of receptor alpha 2 subunits to gephyrin. J. Neurosci. 28, 1356 1365.
54. Tsuneki H., Salas R. Dani J. A. (2003) Mouse muscle denervation increases expression of an alpha7 nicotinic receptor with unusual pharmacology. J. Physiol. 547, 169 179.
55. Wang H., Yu M., Ochani M. et al. (2003) Nicotinic acetylcholine receptor alpha7 subunit is an essential regulator of inflammation. Nature 421, 384 388.
56. Whiteaker P., Jimenez M., McIntosh J. M., Collins A. C. Marks M. J. (2000a) Identification of a novel nicotinic binding site in mouse brain using [(125)I]-epibatidine. Br. J. Pharmacol. 131, 729 739.
57. Whiteaker P., McIntosh J. M., Luo S., Collins A. C. Marks M. J. (2000b) 125I-alpha-conotoxin MII identifies a novel nicotinic acetylcholine receptor population in mouse brain. Mol. Pharmacol. 57, 913 925.
58. Whiteaker P., Christensen S., Yoshikami D., Dowell C., Watkins M., Gulyas J., Rivier J., Olivera B. M. McIntosh J. M. (2007) Discovery, synthesis, and structure activity of a highly selective alpha7 nicotinic acetylcholine receptor antagonist. Biochemistry 46, 6628 6638.
59. Whiteaker P., Marks M. J., Christensen S., Dowell C., Collins A. C. McIntosh J. M. (2008) Synthesis and characterization of 125I-alpha-conotoxin ArIB[V11L;V16A], a selective alpha7 nicotinic acetylcholine receptor antagonist. J. Pharmacol. Exp. Ther. 325, 910 919.
60. Xiao Y. Kellar K. J. (2004) The comparative pharmacology and up-regulation of rat neuronal nicotinic receptor subtype binding sites stably expressed in transfected mammalian cells. J. Pharmacol. Exp. Ther. 310, 98 107.
61. Xiao Y., Meyer E. L., Thompson J. M., Surin A., Wroblewski J. Kellar K. J. (1998) Rat alpha3beta4 subtype of neuronal nicotinic acetylcholine receptor stably expressed in a transfected cell line: pharmacology of ligand binding and function. Mol. Pharmacol. 54, 322 333.
62. Xiao Y., Abdrakhmanova G. R., Baydyuk M., Hernandez S. Kellar K. J. (2009) Rat neuronal nicotinic acetylcholine receptors containing alpha7 subunit: pharmacological properties of ligand binding and function. Acta Pharmacol. Sin. 30, 842 850.
63. Zhao L., Kuo Y. P., George A. A., Peng J. H., Purandare M. S., Schroeder K. M., Lukas R. J. Wu J. (2003) Functional properties of homomeric, human alpha 7-nicotinic acetylcholine receptors heterologously expressed in the SH-EP1 human epithelial cell line. J. Pharmacol. Exp. Ther. 305, 1132 1141.
64. Zhao C., Anand R. Braunewell K. H. (2009) Nicotine-induced Ca2+-myristoyl switch of neuronal Ca2+ sensor VILIP-1 in hippocampal neurons: a possible crosstalk mechanism for nicotinic receptors. Cell. Mol. Neurobiol. 29, 273 286.
65. Zhong C., Du C., Hancock M., Mertz M., Talmage D. A. Role L. W. (2008) Presynaptic type III neuregulin 1 is required for sustained enhancement of hippocampal transmission by nicotine and for axonal targeting of alpha7 nicotinic acetylcholine receptors. J. Neurosci. 28, 9111 9116.